21st-century medicine needs the results of all clinical trials to be made public - even those the drugs companies would rather withhold. A new EU regulation could help make that happen - but the current draft is flawed.
"There is a new EU Clinical Trials Regulation currently passing through parliament in Brussels. It is currently in draft form, and riddled with holes: essentially it allows companies and researchers to withhold trial results, and play fast and loose with analyses. These problems are best documented in the BMJ by one of the co-founders of Cochrane:
www.bmj.com/content/345/bmj.e8522 " (Ben Goldacre, http://www.badscience.net/2013/02/labours-eu-lead-on-clinical-trials-leads-transparency-drive-hurrah/)
See also http://www.alltrials.net/ and Twitter #alltrials.
Posted: 19 February 2013 (Updated: 14 April 2015)